Uri Birenberg
Chief Financial Officer at IM Cannabis
Diluted loss per share for Q4 twenty twenty four was 0.32 compared to a loss of 1.47 per share in Q4 twenty twenty three. As of the balance sheet, cash and cash equivalent as of 12/31/2024 were £900,000 compared to £1,800,000 on 12/31/2023. Total assets as of 12/31/2024 were 39,200,000.0 compared to 48,800,000.0 on 12/31/2023, a decrease of 9,600,000.0 or 19.7%. The decrease is mainly attributed to the Roanem agreement cancellation of 9,500,000.0, of which mainly attributed to goodwill 3,500,000.0 intangible asset CHF 1,400,000.0 inventory CHF 800,000.0 trade receivables CHF 1,300,000.0 property, plant and equipment CHF 800,000.0 and reduction of cash and cash equivalent of CHF $300,000 In addition to the Ronin Revocation Agreement effect, there is a total asset decrease of $100,000 mainly due to the increase of $7,500,000 in trade receivable offset by £5,900,000 reduction in inventory and the reduction of £1,100,000 in intangible assets. Total liabilities as of 12/31/2024 were £36,000,000 compared to 35,100,000.0 on 12/31/2023, an increase of 900,000 or 3%.